We are live on ! Find out more
Natixis Advisors

Natixis Advisors Portfolio holdings

AUM $71.9B
1-Year Est. Return 28.03%
This Fund
S&P 500
This Quarter Est. Return
+5.52%
1 Year Est. Return
+28.03%
3 Year Est. Return
+95.12%
5 Year Est. Return
+131.42%
10 Year Est. Return
+475.22%
AUM
$7.72B
AUM Growth
+$487M
Cap. Flow
+$164M
Cap. Flow %
2.12%
Top 10 Hldgs %
12.79%
Holding
1,037
New
61
Increased
505
Reduced
426
Closed
45

Top Buys

Rank Stock Value
1
REGN icon
Regeneron Pharmaceuticals
REGN
+$28.2M
2
IWN icon
iShares Russell 2000 Value ETF
IWN
+$18.5M
3
DE icon
Deere & Co
DE
+$15.6M
4
TSM icon
TSMC
TSM
+$13.2M
5
C icon
Citigroup
C
+$13.2M

Sector Composition

Rank Sector Weight
1 Financials 14.75%
2 Technology 13.63%
3 Healthcare 12.63%
4 Industrials 10.5%
5 Consumer Discretionary 9.16%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CMCSA icon
26
Comcast
CMCSA
$78.3B
$47.1M 0.61%
1,420,974
+15,250
+1% +$508K
VBK icon
27
Vanguard Small-Cap Growth ETF
VBK
$23.4B
$46.5M 0.6%
352,933
+873
+0.2% +$114K
ADSK icon
28
Autodesk
ADSK
$43.3B
$45.7M 0.59%
631,677
-4,868
-0.8% -$307K
UPS icon
29
United Parcel Service
UPS
$97B
$45.7M 0.59%
417,658
+18,929
+5% +$2.07M
EFV icon
30
iShares MSCI EAFE Value ETF
EFV
$27.3B
$45.4M 0.59%
984,020
+49,614
+5% +$2.23M
ACN icon
31
Accenture
ACN
$84.9B
$44.8M 0.58%
366,960
-67,013
-15% -$7.63M
WFC icon
32
Wells Fargo
WFC
$261B
$44.6M 0.58%
1,006,756
-27,158
-3% -$1.3M
TSM icon
33
TSMC
TSM
$2.16T
$43.1M 0.56%
1,408,500
+463,237
+49% +$13.2M
BRK.B icon
34
Berkshire Hathaway Class B
BRK.B
$1.06T
$42.9M 0.56%
296,726
+32,312
+12% +$4.73M
C icon
35
Citigroup
C
$221B
$42.3M 0.55%
896,463
+290,009
+48% +$13.2M
NVO
36
Novo Nordisk
NVO
$213B
$41.7M 0.54%
2,006,476
+200,582
+11% +$4.97M
AMGN icon
37
Amgen
AMGN
$201B
$38.5M 0.5%
230,986
+27,109
+13% +$4.58M
EXPD icon
38
Expeditors International
EXPD
$23B
$38.3M 0.5%
744,139
+45,249
+6% +$2.29M
SEIC icon
39
SEI Investments
SEIC
$11.6B
$37.1M 0.48%
813,835
+46,698
+6% +$2.19M
PFE icon
40
Pfizer
PFE
$143B
$37M 0.48%
1,151,940
+120,164
+12% +$4.02M
VAR
41
DELISTED
Varian Medical Systems, Inc.
VAR
$35.8M 0.46%
410,123
+19,614
+5% +$1.6M
BKNG icon
42
Booking.com
BKNG
$134B
$35.7M 0.46%
606,875
+19,200
+3% +$1.07M
UL icon
43
Unilever
UL
$130B
$34.9M 0.45%
655,323
-8,645
-1% -$457K
CERN
44
DELISTED
Cerner Corp
CERN
$33.2M 0.43%
538,078
+28,651
+6% +$1.81M
EFA icon
45
iShares MSCI EAFE ETF
EFA
$76.1B
$32.9M 0.43%
556,860
+7,471
+1% +$433K
WBA
46
DELISTED
Walgreens Boots Alliance
WBA
$32.8M 0.43%
407,446
+10,451
+3% +$852K
BTI icon
47
British American Tobacco
BTI
$129B
$32.3M 0.42%
506,152
+17,326
+4% +$1.1M
YUM icon
48
Yum! Brands
YUM
$40.6B
$31.8M 0.41%
487,070
+28,403
+6% +$1.81M
MDT icon
49
Medtronic
MDT
$105B
$31.5M 0.41%
365,016
-29,760
-8% -$2.59M
PM icon
50
Philip Morris
PM
$298B
$30.1M 0.39%
309,875
+17,605
+6% +$1.76M

Similar funds

Natixis Advisors's Q3 2016 Portfolio in Review

As of Q3 2016, Natixis Advisors held 1,037 positions worth $7.72B, up 6.7% from $7.23B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

Natixis Advisors's Q3 2016 filing shows 61 new, 505 increased, 426 reduced and 45 closed positions. Its largest new stake was Regeneron Pharmaceuticals: 70,417 shares worth $28.3M. The largest sale was ARM HOLDINGS PLC ADS, an estimated $36.5M.

By sector, the portfolio is most concentrated in Financials at 15% of assets, up from 14% a quarter earlier, followed by Technology and Healthcare.

  • Natixis Advisors's largest Q3 2016 buy was Regeneron Pharmaceuticals: 70,417 shares worth $28.3M.
  • Natixis Advisors added most to TSMC in Q3 2016, an estimated $13.2M increase.
  • Natixis Advisors's biggest Q3 2016 reduction was Hertz Global Holdings, Inc., cutting an estimated $15.6M.
  • Natixis Advisors fully exited ARM HOLDINGS PLC ADS in Q3 2016, selling an estimated $36.5M.
  • Natixis Advisors's ten largest holdings make up 13% of its $7.72B portfolio in Q3 2016.
  • Natixis Advisors opened 61 new positions and closed 45 in Q3 2016.
  • Natixis Advisors's portfolio value rose 6.7% quarter-over-quarter to $7.72B.

Based on Natixis Advisors's 13F filing for Q3 2016, filed 4 Nov 2016.